Remarkably, apart from a biased usage of the immunoglobulin genes and mutations in the BCR complex in a specific small subset of CLL patients, there are no recurrent genetic mutations within the components of the BCR signaling cascade. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.